Effect of ethanol on metabolic syndrome;Wpływ alkoholu etylowego na zespół metaboliczny

Polskie Archiwum Medycyny Wewnetrznej

Volumn 117, Issue 7, 2007, Pages 306-311

  Jelski, Wojciech ^a   Szmitkowski, Maciej ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Ethanol; Metabolic syndrome

Indexed keywords

ALCOHOL; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; NITRIC OXIDE; PEROXIDE; PEROXYNITRITE; POLYPHENOL;

ALCOHOL CONSUMPTION; BIOACCUMULATION; CHOLESTEROL BLOOD LEVEL; DIET RESTRICTION; DISEASE ASSOCIATION; DYSLIPIDEMIA; ENZYME ACTIVATION; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INCIDENCE; INSULIN RESISTANCE; LIPID BLOOD LEVEL; METABOLIC SYNDROME X; PATHOGENESIS; RED WINE; REVIEW; UPREGULATION; WAIST CIRCUMFERENCE;

EID: 35349020985     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.164     Document Type: Review

References (43)

1. Reaven GM. The metabolic sydrome, requiescat in pace. Clin Chem. 2005; 51: 93-98.
2. Janeczko D. Zespół metaboliczny - epidemia XXI wieku. Przew Lek. 2005; 3: 14-27.
3. Executive Summary of the Third Report of the National Education Program (NCLP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001; 248-2497.
4. Kahn R, Buse J, Ferrannini E, et al. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2005; 28: 2289-2304.
5. Kociecki M. Zespół metaboliczny w roku 2006. Przegl Kard. 2006; 1: 55-60.
6. Ravanglia G, Forti P, Maioli F, et al. Metabolic Syndrome: prevalence and prediction of mortality in elderly individuals. Diabetes Care. 2006; 29: 2471-2476.
7. Despres JP. Is visceral obesity the cause of the metabolic syndrome? Ann Med. 2006; 38: 52-63.
8. Kato H, Kashiwagi H, Shiraga M, et al. Adiponectin acts as an endogenous antithrombotic factor. Arterioscler Thromb Vasc Biol. 2006; 26: 224-230.
9. Kopff B, Jegier A. Wysiłek fizyczny a wybrane adipokiny: adiponektyna, leptyna i rezystyna. Pol Arch Med Wewn. 2006; 116: 73-84.
10. Okamoto Y, Kihara S, Funahashi T, et al. Adiponectin: a key adipocytokin in metabolic syndrome. Clin Sci. 2006; 110: 267-278.
11. Reaven GM. Role of insulin resistance in human disease. Diabetes. 1998; 37: 1595-1607.
12. Tan K, Chow WS, Ai VH, et al. Advanced glycation end products and endothelial dysfunction in type 2 diabetes. Diabetes Care. 2002; 25: 1055-1059.
13. Meigs JB, Hu FB, Rifai N, et al. Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA. 2003; 291: 1978-1986.
14. Ronnback M, Isomaa B, Fagerudd J, et al. Complex relationship between blood pressure and mortality in type 2 diabetic patients: a follow-up of the Botnia Study. Hypertension. 2006; 47: 168-173.
15. Kałka D, Sobieszczańska M, Marciniak W, et al. Zależność ciśnienia tȩtniczego od indeksu masy ciała u pacjentów z choroba̧, niedokrwienna̧, serca poddanych rehabilitacji kardiologicznej. Pol Arch Med Wewn. 2006; 116: 741-748.
16. Steciwko A, Reksa D, Grotowska M. Śródbłonek i jego rola w patogenezie różnych jednostek chorobowych. Pol Arch Med Wewn. 2006; 116: 819-831.
17. Gardner CD, Fortmann SP, Krauss RM. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA. 1996; 276: 875-881.
18. Gott AM, Brinton EA. Assessing low levels of high-density lipoprotein cholesterol as a risk factor in coronary heart disease: a working group report and update. J Am Cardiol. 2004; 43: 717-724.
19. Goude D, Fagerberg G, Hulthe J. Alcohol consumption, the metabolic syndrome and insulin resistance in 58-year-old clinically healthy men. Clin Sci. 2002; 102: 345-352.
20. Yoon YS, Oh SW, Baik H, et al. Alcohol consumption and the metabolic syndrome in Korean adults: the 1998 Korean National Health and Nutrition Examination Survey. Am J Clin Nutr. 2004; 80: 217-224.
21. Freiberg MS, Cabral HJ, Heeren TC, et al. Alcohol consumption and the prevalence of the Metabolic Syndrome in the US.: a cross-sectional analysis of data from the Third National Health and Nutrition Examination Survey. Diabetes Care. 2004; 27: 2954-2959.
22. Rimm EB, Williams P, Fosher K, et al. Moderate alcohol intake and lower coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. BMJ. 1999; 319: 1523-1528.
23. Savolainen MJ, Kesaniemi YA. Effects of alcohol lipoproteins in relation to coronary heart disease. Curr Opin Lipidol. 1995; 6: 243-250.
24. Hannuksela M, Marcel YL, Kesaniemi YA. Reduction in the concentration and activity of plasma cholesteryl ester transfer protein by alcohol. J Lipid Res. 1992; 33: 737-744.
25. Stampfer MJ, Krauss RM, Ma J, et al. A prospective study of trigliceryde level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA. 1996; 276: 882-888.
26. Sieradzki J. Zespól metaboliczny - wznowiona dyskusja. Terapia. 2006; 5: 29-32.
27. Sakurai Y, Umeda T, Shinchi K. et al. Relation of total and beverage-specific alcohol intake to body mass index and waist-to-hip ratio: a study of self-defense officials in Japan. Eur J Epidemiol. 1997; 13: 893-898.
28. Liu S, Serdula MK, Williamson D, et al. A prospective study of alcohol intake and change in body weight among US adults. Am J Epidemiol. 1994; 140: 912-920.
29. Duncan BB, Chambless LE, Schmidt MI, et al. Association of the waist-to-hip ratio is different with wine than with beer or hard liquor consumption. Atherosclerosis Risk in Communities Study Investigators. Am J Epidemiol. 1995; 142: 1034-1038.
30. Polskie Forum Profilaktyki. Alkohol a choroby układu sercowo-naczyniowego. 2006; 1: 1-8.
31. Greenhouse L, Lardinois CK. Alcohol-associated diabetes mellitus. A review of the impact of alcohol consumption on carbohydrate metabolism. Arch Fam Med. 1996; 5: 229-233.
32. Xu D, Dhillon AS, Abelmann A, et al. Alcohol - related diols cause acute insulin resistance in vivo. Metabolism. 1998; 47: 1180-1187.
33. Cox WM, Blount JP, Crowe PA, et al. Diabetic patients alcohol use and quality of life: relationships with prescribed treatment compliance among older males. Alcohol Clin Exp Res. 1996; 20: 327-331.
34. Holbrook T, Barrett-Connor E, Wingard D. A prospective population-based study of alcohol use and non-insulin-dependent diabetes mellitus. Am J Epidemiol. 1990; 132: 902-909.
35. Tsumura K, Hayashi T, Suematsu C, et al. Daily alcohol consumption and the risk of type 2 diabetes in Japanese men: the Osaka. Diabetes Care. 1999; 22: 1432-1437.
36. Carlsson S, Hammar N, Efendic S, et al. Alcohol consumption. Type 2 diabetes mellitus and impaired glucose tolerance in middle-aged Swedish men. Diabet Med. 2000; 17: 776-781.
37. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report JAMA. 2003; 289: 2560-2572.
38. Corder R, Douthwaite JA, Lees DM, et al. Endothelin-1 synthesis reduced by red wine. Nature 2001; 414: 863-864.
39. Leikert JF, Rathel TP, Wohlfart P, et al. Red wine polyphenols enhance endothelial nitric oxide synthase expression and subsequent nitric oxide release from endothelial cells. Circulation. 2002; 106: 1614-1617.
40. Leighton F, Miranda-Rottmann S, Urquiaga I. A central role of eNOS in the protective effect of wine against metabolic syndrome. Cell Biochem Funct. 2006; 24: 291-298.
41. Landmesser U, Dikalov S, Price SR, et al. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest. 2003; 111: 1201-1209.
42. Gurnell M, Savage DB, Chatterjee VK, et al. The metabolic syndrome: peroxisome proliferator - activated receptor gamma and its therapeutic modulation. J Clin Endocrinol Metab. 2003; 88: 2412-2421.
43. Stoclet JC, Kleschyov A, Andraimbeloson E, et al. Endothelial NO release cased by red wine polyphenols. J Physiol Pharmacol. 1999; 50: 535-540.